Home/Filings/4/0001062993-23-008033
4//SEC Filing

GRIFFIN MICHELLE RENEE 4

Accession 0001062993-23-008033

CIK 0001478320other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 5:01 PM ET

Size

5.3 KB

Accession

0001062993-23-008033

Insider Transaction Report

Form 4
Period: 2023-03-27
Transactions
  • Sale

    Common Stock

    2023-03-27$8.49/sh2,341$19,87820,627 total
Footnotes (2)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
  • [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.41 to $8.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

Issuer

Adaptive Biotechnologies Corp

CIK 0001478320

Entity typeother

Related Parties

1
  • filerCIK 0001229765

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 5:01 PM ET
Size
5.3 KB